- Home
- RNA vs AMED Comparison
RNA vs AMED Comparison
Compare RNA & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- AMED
- Stock Information
- Founded
- RNA 2012
- AMED 1982
- Country
- RNA United States
- AMED United States
- Employees
- RNA N/A
- AMED N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- AMED Medical/Nursing Services
- Sector
- RNA Health Care
- AMED Health Care
- Exchange
- RNA Nasdaq
- AMED Nasdaq
- Market Cap
- RNA 3.7B
- AMED 3.0B
- IPO Year
- RNA 2020
- AMED N/A
- Fundamental
- Price
- RNA $29.52
- AMED $92.63
- Analyst Decision
- RNA Strong Buy
- AMED Hold
- Analyst Count
- RNA 12
- AMED 7
- Target Price
- RNA $68.25
- AMED $100.80
- AVG Volume (30 Days)
- RNA 1.4M
- AMED 304.4K
- Earning Date
- RNA 05-08-2025
- AMED 04-23-2025
- Dividend Yield
- RNA N/A
- AMED N/A
- EPS Growth
- RNA N/A
- AMED N/A
- EPS
- RNA N/A
- AMED 1.31
- Revenue
- RNA $10,897,000.00
- AMED $2,348,324,000.00
- Revenue This Year
- RNA N/A
- AMED $7.31
- Revenue Next Year
- RNA $230.08
- AMED $5.63
- P/E Ratio
- RNA N/A
- AMED $70.76
- Revenue Growth
- RNA 13.98
- AMED 5.00
- 52 Week Low
- RNA $21.56
- AMED $82.15
- 52 Week High
- RNA $56.00
- AMED $98.95
- Technical
- Relative Strength Index (RSI)
- RNA 43.70
- AMED 54.35
- Support Level
- RNA $30.12
- AMED $91.32
- Resistance Level
- RNA $33.13
- AMED $92.97
- Average True Range (ATR)
- RNA 2.14
- AMED 0.68
- MACD
- RNA -0.05
- AMED -0.00
- Stochastic Oscillator
- RNA 11.94
- AMED 67.88
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.